Xiuling Lu, Ph.D.

UConn Today: Nami Therapeutics Startup Pursues Promising Drug Therapy
News Medical: Nanotechnologies can lead to big advances in cancer therapy

UConn Today: Research Holds Promise for Improved Treatment of Ovarian Cancer

Nami Therapeutics Corp. was selected to participate in the Connecticut Center for Entrepreneurship and Innovation program

Featured Faculty: Xiuling Lu from @UConnPharmacy is actively commercializing nanoparticle-based drug delivery platforms developed in her lab.